-
As people throughout the nation struggle to recover from tornadoes, floods, and other weather-related emergencies, the National Hospice Foundation (NHF) is making funds available to support state organizations as they respond to recovery efforts of providers at the local level.
-
A new publication to help with the implementation of Concurrent Care for Children Requirement (CCCR) is available at no cost on the National Hospice and Palliative Care Organization (NHPCO) web site.
-
A position statement and commentary, Hospice and Palliative Care: Ethical Marketing Practices, was recently released by the National Hospice and Palliative Care Organization (NHPCO).
-
Elders who ate sorbet before a meal ate more of the rest of their meal.
-
A very low energy diet followed by a weight maintenance program results in significant improvements in weight, obstructive sleep apnea, metabolic factors, and quality for at least a year.
-
A second NS3/4A protease inhibitor has been approved by the FDA for the treatment of chronic hepatitis C (HCV) genotype 1, joining the recently approved boceprevir (Victrelis). Telaprevir is marketed by Vertex Pharmaceuticals as Incivek.
-
-
Proton pump inhibitor use in clopidogrel-treated post-percutaneous coronary intervention patients was not associated with an increased risk of all-cause death, nonfatal myocardial infarction, repeat revascularization, or major adverse cardiovascular events.
-
-
Cerebrovascular events (CVE), including stroke and transient ischemic attack (TIA), are recognized complications of percutaneous coronary intervention (PCI).
